VIVK · Vivakor, Inc. · Insider Trading

Shares issued for Board of Directors fees.

Issued as compensation per terms of Employment Agreement dated July 24, 2025. Per the terms of the Employment Agreement, these shares were valued at $0.128 per share.

Transaction Code J-Shares were transferred to a financial institution as collateral under the terms of the loan agreement. Shares were valued based on closing price of the Issuer's common stock on 11/10/2025. Value to be applied against the loan balance.

Transaction Code J-Shares were transferred to a financial institution as collateral under the terms of the loan agreement. Shares were valued based on closing price of the Issuer's common stock on 11/10/2025. Value to be applied against the loan balance.

Shares issued for Board of Directors fees.

Shares issued for Board of Directors fees.

The average purchase price per share of $1.7832941 based on the total price of $250,000.00.

The average purchase price per share of $0.5921 based on the total price of $250,000.00.

The average purchase price per share of $1.5335 based on the total price of $19,340.76.

The average purchase price per share of $1.5235 based on the total price of $23,064.46.

The average purchase price per share of $1.3476 based on the total price of $56,731.22.

The average purchase price per share of $1.37 based on the total price of $20,893.57.

The average purchase price per share of $1.27 based on the total price of $52,537.80.

The average purchase price per share of $1.29 based on the total price of $39,804.00.

The average purchase price per share of $1.59 based on the total price of $75,443.10.

The average purchase price per share of $1.44 based on the total price of $78,389.23.

The average purchase price per share of $1.37 based on the total price of $189,550.

The average purchase price per share of $1.12 based on the total price of $33,529.

The average purchase price per share of $0.5921 based on the total price of $250,000.00.

Shares issued for Board of Directors fees.

Shares issued to Jorgan Development, LLC ("Jorgan"), in exchange for forgiveness and cancellation of the note payable in the amount of $10,000,000.68 per the terms of a Membership Interest Purchase Agreement between Jorgan and the Issuer dated August 1, 2022.

Mr. Ballengee has beneficial ownership of shares owned by Jorgan Development, LLC (10,021,710 shares) and JBAH Holdings, LLC (30,096 shares).

The shares issued to James Ballengee pursuant to his employment agreement with the Issuer, pursuant to which $1,000,000 in shares were to be issued priced at the volume weighted average price (VWAP) for the five trading days preceding the effective date of the employment agreement, which was $1.082635 per share.

32 transactions were executed on November 28, 2022 to purchase an aggregate amount of 44,700 shares with the weighted average share price of $1.021.

Mr. Ballengee has beneficial ownership of shares owned by Jorgan Development, LLC (2,979,456 shares) and JBAH Holdings, LLC (30,096 shares).

45 transactions were executed on November 25, 2022 to purchase an aggregate amount of 55,300 shares with the weighted average share price of $0.9925.

Mr. Ballengee has beneficial ownership of shares owned by Jorgan Development, LLC (2,979,456 shares) and JBAH Holdings, LLC (30,096 shares).

Pursuant to the terms of the Director Compensation Schedule with equity issuances adopted by the Board of Directors of the Company, dated October 24, 2022 (the "Effective Date"), Mr. Ferrara was granted stock options to purchase up to 100,000 shares of the Company's common stock, par value $0.001 per share, at an exercise price of $2.50 per share (the "Stock Options"). The Stock Options shall vest immediately on the Effective Date.

Pursuant to the terms of the Director Compensation Schedule with equity issuances adopted by the Board of Directors of the Company, dated October 24, 2022 (the "Effective Date"), Mr. Staggs was granted stock options to purchase up to 100,000 shares of the Company's common stock, par value $0.001 per share, at an exercise price of $2.50 per share (the "Stock Options"). The Stock Options shall vest immediately on the Effective Date.

On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Matthew Nicosia. Pursuant to the Agreement, the Company granted Mr. Nicosia a stock option to acquire 955,053 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 278,356 of the shares vesting immediately, 225,579 of the shares vesting three (3) months after issuance, and the remaining 451,158 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (64,451 for 6 quarters and 64,642 in the last quarter), with an exercise price equal to 110% of the fair market value on the date grant, and which expires five (5) years after the date of grant.

On June 9, 2022, Vivakor, Inc. (the "Company") entered into an Executive Employment Agreement (the "Agreement") with Tyler Nelson. Pursuant to the Agreement, the Company granted Mr. Nelson a stock option to acquire 917,825 shares of the Company's common stock (the "Stock Option"). The Stock Option will vest over two years with 360,145 of the shares vesting immediately, 219,312 of the shares vesting three (3) months after issuance, and the remaining 338,368 of the shares vesting in equal quarterly installments over the remaining seven (7) quarters (48,338 for 6 quarters and 48,340 in the last quarter), with an exercise price equal to 100% of the fair market value on the date grant, and which expires ten (10) years after the date of grant.

Mr. Nicosia purchased 628 of the February 23, 2022 Purchased Shares at $2.50 per Common Stock, and the remaining 2,900 February 23, 2022 Purchased Shares at $2.65 per Common Stock.

On February 23, 2022, Mr. Nicosia made a private purchase in the open market of 3528 shares of Common Stock, par value $0.001 per share ("Common Stock") (the "February 23, 2022 Purchased Shares").

The total number of Common Stock beneficially owned by Mr. Nicosia includes (i) 4,189,428 Common Stock are held by AKMN Irrevocable Trust, of which Mr. Nicosia is a trustee; (ii) 262 Common Stock are held by Nicosia Family Trust, and (iii) 4438.51 Common Stock are held directly by Mr. Nicosia.

The February 23, 2022 Purchased Shares are held directly by Mr. Nicosia.

On February 17, 2022, the Reporting Person made a private purchase in the open market of 320 shares of shares of Common Stock, par value $0.001 per share ("Common Stock") (the "February 17, 2022 Shares").

The total number of Common Stock beneficially owned by Mr. Nicosia, includes (i) 4,189,428 Common Stock held by AKMN Irrevocable Trust, of which Mr. Nicosia is a trustee; (ii) 262 Common Stock held by Nicosia Family Trust, and (iii) 910.51 Common Stock are owned directly by Mr. Nicosia.

The February 17, 2022 Shares are owned directly by Mr. Nicosia.

On February 16, 2022, the Reporting Person made a private purchase in the open market of 320 shares of shares of Common Stock, par value $0.001 per share.

The shares of common stock ("Common Stock") beneficially owned by Matthew Nicosia includes 4,189,428 Common Stock held by AKMN Irrevocable Trust and 262 Common Stock held by Nicosia Family Trust. Matthew Nicosia is the trustee of the AKMN Irrevocable Trust.

On February 16, 2022, the Reporting Person made a private purchase in the open market of 590.51 shares of Common Stock, par value $0.001 per share ("Common Stock").

The total number of Common Stock beneficially owned by Mr. Nicosia, includes (i) 4,189,428 Common Stock held by AKMN Irrevocable Trust, of which Mr. Nicosia is a trustee; (ii) 262 Common Stock held by Nicosia Family Trust, and (iii) 590.51 Common Stock are owned directly by Mr. Nicosia.